PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Malaria-causing parasites resistant to both treatment and detection have emerged in Ethiopia

Genomic surveillance by a Brown-led team of scientists has revealed mutations in malaria-causing parasites that will complicate efforts to eradicate the disease in Africa.

2023-09-11
(Press-News.org) PROVIDENCE, R.I. [Brown University] — Scientists have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests — a development that could increase cases and deaths from malaria and make eliminating the persistent disease an even greater challenge.

The authors detailed their findings from a genomic surveillance study in Nature Microbiology. Already, scientists had found in Uganda, Tanzania and Rwanda strains of the parasite that causes malaria that were resistant to most available antimalarial drugs; and separately, malaria parasites resistant to diagnostic tests had emerged in the Horn of Africa.

Those parasites have been spreading independently of one another, but the new study is the first published report to confirm the prevalence of this type of double-resistant malaria strain, said study author Jeffrey Bailey, an associate professor of translational research and pathology and laboratory medicine at Brown University.

“Now we're essentially seeing the worst-case scenario: parasites with the mutation that make them resistant to treatment have also picked up the chromosomal deletions that make them invisible to the diagnostic tests,” Bailey said. “This means that it will be harder to detect people who are infected, and then when infected people are treated with antimalarial drugs, that may not work to stop them from spreading the disease.”

The standard method to diagnose malaria in Africa is through rapid diagnostic tests that detect specific parasite proteins in the blood that are highly expressed. The tests can confirm malaria even if the patient is asymptomatic. The parasites lacking the genes for these proteins have evolved to be invisible to the tests. 

The first-line malaria treatment recommended by the World Health Organization is a combination therapy involving artemisinin-based drug compounds, which tend to be very effective in preventing death and reducing transmission. The mutations now detected in Africa provide resistance to artemisinin.

Bailey’s research team at Brown, in close collaboration with the researchers from the Ethiopian Public Health Institute and the University of North Carolina at Chapel Hill, conducted a comparative genomic analysis of malaria-parasite samples with the deleted protein-expressing genes that had been collected across three regions of Ethiopia. Led by Bailey, co-director of the Ph.D. program at Brown’s Center for Computational Molecular Biology, the scientists used molecular sequencing to assess the prevalence of mutations that confer resistance to artemisinin. Abebe Fola, a postdoctoral researcher in Bailey’s lab, was instrumental in this work and is the first author of the paper.

They found that 8.2% of drug-resistant parasites also carried the deletions of the protein-expressing gene that made them detectable by the diagnostic tests.

In Ethiopia, the overall incidence of malaria is low, but the disease remains endemic in 75% of the country, with 65% of the population at risk. More than 5 million episodes of malaria occur each year. The Ethiopian government set a goal for malaria elimination by 2030, and prompt diagnosis and treatment with effective drugs is a cornerstone of the malaria elimination program.

“The spread of these parasites will certainly make eliminating malaria in Ethiopia and elsewhere in Africa more difficult and will likely lead to increased cases and deaths,” Bailey said.

The scientists concluded that close monitoring of the spread of combined drug- and diagnostic-resistant parasites is needed, noting that improved understanding of how these mutations emerge, interact and spread is critical to the success of future malaria control and elimination efforts across Africa.

In addition, Bailey said, there is an urgent need to develop new therapies, in addition to artemisinin, to treat malaria as well as vaccines to prevent and slow the spread of the disease.

The ability to conduct genomic surveillance to monitor mutations while looking for new ones has greatly advanced over the last decade, Bailey said, with the emergence and refinement of next-generation sequencing. His lab at Brown has pioneered high-throughput techniques to sequence many genes at once, and has been collaborating on projects like the current study with research teams at other universities as well as health agencies in countries such as Uganda. While the analysis for this study was conducted at Brown, Bailey and others on the research team are working on building the capacity for genomic surveillance in Ethiopia and other parts of Africa.

The project was funded in part by the U.S. National Institutes of Health (R01AI132547, K24AI134990, R01AI1777791); the Ministry of Health-Ethiopia (EPHI5405); and the Bill and Melinda Gates Foundation through the World Health Organization (OPP1209843).

END


ELSE PRESS RELEASES FROM THIS DATE:

$3.5 million NIH grant funds the first-ever clinical trial of ketone supplementation to treat and or prevent frailty

2023-09-11
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.  TAKEOFF (Targeting Aging with Ketone Ester in Older Adults for Function in Frailty) will recruit a total of 180 people at the Buck, Ohio State University and the University of Connecticut Center on Aging.   “TAKEOFF ...

Scientific ocean drilling discovers dynamic carbon cycling in the ultra-deep-water Japan Trench

Scientific ocean drilling discovers dynamic carbon cycling in the ultra-deep-water Japan Trench
2023-09-11
The Japan Trench is located on the “Pacific Ring of Fire”, a region of special interest in earthquake and deep-water research. “It is here that oceanic plates bend, form ultra-deep-water trenches and move below overriding plates in so-called subduction zones, while accumulating long-term global plate tectonic strain”, says Dr. Ken Ikehara from National Institute of Advanced Industrial Science and Technology, Japan, and co-chief scientist of IODP Expedition 386. “This energy is released cataclysmically during so-called megathrust earthquakes, ...

University of Houston researchers charting a sustainable course in oceanic carbon capture

2023-09-11
As researchers around the world race against time to develop new strategies and technologies to fight climate change, a team of scientists at the University of Houston is exploring one possible way to directly reduce the amount of carbon dioxide in the environment: Negative emissions technologies (NETs). Mim Rahimi, assistant professor of environmental engineering at UH’s Cullen College of Engineering is leading the development of an emerging NET called electrochemical direct ocean capture (eDOC), which helps the ocean cleanse itself of harmful carbon dioxide. The concept ...

Antidepressants may reduce negative memories while improving overall memory, according to Rice study

2023-09-11
New research from Rice University finds that antidepressants may actually reduce negative memories in individuals suffering from depression while improving overall memory function.    The study, “Perceived antidepressant efficacy associated with reduced negative and enhanced neutral mnemonic discrimination,” appears in the latest edition of Frontiers in Human Neuroscience. It examines how antidepressant use in depressed individuals affects memories, both good and bad.    Stephanie Leal, an assistant professor of psychological sciences at Rice, is the study’s lead author. She said the study’s main finding about the link between antidepressants ...

Hybrid catalyst produces critical fertilizer and cleans wastewater

Hybrid catalyst produces critical fertilizer and cleans wastewater
2023-09-11
Agriculture relies on synthetic nitrogen fertilizer, which is made using energy- and carbon-intensive processes and creates nitrate-containing runoff. Researchers have long sought solutions to reduce emissions from the industry that accounts for 3% of energy consumption each year. A collaboration between two labs at Northwestern University, partnering with the University of Toronto, has found that producing the fertilizer urea using electrified synthesis could both denitrify wastewater while enabling low-carbon-intensity urea production. The process, which includes converting carbon ...

UNIST signs cooperation MoU with Eswatini Medical Christian University

UNIST signs cooperation MoU with Eswatini Medical Christian University
2023-09-11
UNIST has taken a significant step towards combating women’s cancer on the African continent by signing an MOU with Eswatini Medical Christian University (EMCU) on June 28, 2023. The primary purpose of this partnership is to enhance cooperation in the diagnosis and treatment of cervical cancer, marking the beginning of a promising initiative. Under this agreement, UNIST will lead research and development efforts in cervical cancer diagnosis and treatment technologies, while EMCU will provide a clinical test bed for these advancements. The ...

OSE Immunotherapeutics announces: positive phase 3 data from its cancer vaccine in lung cancer patients with resistance to previous immunotherapy published in Annals of Oncology

2023-09-11
Nantes, France – September 11, 2023, 6:00pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the peer-reviewed publication in Annals of Oncology* of the randomized Phase 3 clinical trial (Atalante-1) on T-cell epitope cancer vaccine Tedopi® in HLA-A2 positive patients with advanced or metastatic NSCLC in monotherapy in third line NSCLC with secondary resistance to immune checkpoint inhibitors (ICI). Tedopi® is a novel T-cell epitope-based cancer vaccine targeting five tumor-associated antigens, ...

Chaplin receives funding for study integrating neural and momentary assessment of parenting, arousal and adolescent substance use

2023-09-11
Tara Chaplin, Associate Professor, Clinical Psychology, received $500,664 from the National Institutes of Health for an Independent Scientist Career Award titled: "Integrating neural and momentary assessment of parenting, arousal, and adolescent substance use."  This Independent Scientist K02 Award will provide Dr. Chaplin with cutting edge advanced training to enhance her career and transform her program of research. Through this training, Dr. Chaplin will integrate ecological momentary assessment (EMA) science into her expertise in developmental neuroscience to understand from a neural and momentary level parenting, emotion, and substance use associations ...

Smith receives funding for watershed programs

2023-09-11
Cynthia Smith, Associate Professor and K12 Education Director, Potomac Environmental Research and Education Center (PEREC), Environmental Science and Policy, received $60,750 from Fairfax County Public Schools for: "FCPS Watershed Programs." This funding began in July 2023 and will end in late June 2024. Since 2010, Smith has worked closely with the FCPS science office to deliver outdoor, hands-on field investigations to 5,200 seventh graders annually. Over 350 Mason students have worked as PEREC field interpreters, honing ...

Moran and Yao to study interpretability for neural language models of source code

2023-09-11
Kevin Moran, Assistant Professor, Computer Science, and Ziyu Yao, Assistant Professor, Computer Science, are set to receive funding from the National Science Foundation for: "Collaborative Research: SHF: Medium: Toward Understandability and Interpretability for Neural Language Models of Source Code." Moran and Yao will develop a framework and methodology that enables researchers who build AI-powered developer tools and software engineers who use these tools to interpret why the underlying models make the predictions they do.  Their objective is to allow researchers to obtain detailed insights into why a model may not ...

LAST 30 PRESS RELEASES:

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

[Press-News.org] Malaria-causing parasites resistant to both treatment and detection have emerged in Ethiopia
Genomic surveillance by a Brown-led team of scientists has revealed mutations in malaria-causing parasites that will complicate efforts to eradicate the disease in Africa.